Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel +/- Vandetanib in Advanced Gastroesophageal Cancer
NCT00683787Phase 2Terminated
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- May 2008
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vandetanib in gastric cancer (GC), gastroesophageal junction cancer, sponsored by Roswell Park Comprehensive Cancer Center. Started May 2008; status: terminated.
02
Drugs
vandetanib
03
Conditions
gastric cancer (GC)gastroesophageal junction cancer
Beyond the preview
Go deeper on NCT00683787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00683787.